Panacea Innovation Ltd - 26 Sep 2025 SCHEDULE 13D Report for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)

Filing Manager
Panacea Innovation Ltd
Reporting Manager
James Huang
Security
CASI Pharmaceuticals, Inc. Ordinary Shares
Symbol
CASI
Shares outstanding
18,399,854 shares
Disclosed Ownership
3,661,571 shares
Ownership
19.9%
Form type
SCHEDULE 13D
Filing time
26 Sep 2025, 18:45:21 UTC
Date of event
26 Sep 2025
Next filing
17 Dec 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Panacea Venture Healthcare Fund II, L.P. 19.4% 3,550,000 0 3,550,000 By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner 0001869939
Panacea Venture Healthcare Fund II GP Company, Ltd. 19.4% 3,550,000 0 3,550,000 By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner
Panacea Innovation Limited 19.4% 3,550,000 0 3,550,000 /s/ James Huang James Huang, Founding Managing Partner 0002010692
James Huang 19.9% 3,661,571 111,571 3,550,000 /s/ James Huang James Huang 0001573160